Report summary

Notifier

Name of person with notification obligation

Johan Giléus

Reason for notification

Closely associated

Person discharging managerial responsibilities

Johan Giléus

Position

Chief Financial Officer (CFO)

Initial notification

Yes

Amendment

Details of amendment

Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor

Name of issuer

InDex Pharmaceuticals Holding AB

Issuer’s LEI code

54930047C4A74IBXR037

Details of transaction

Type of financial instrument	Financial instrument	ISIN code	Nature of transaction	Linked to a share option programme	Volume	Unit	Price per unit	Currency code	Transaction date	Place of the transaction
BTA	InDex Pharmaceuticals Holding AB BTA	SE0015503388	Subscription		200,000	Quantity	1.20	SEK	05/02/2021	FIRST NORTH SWEDEN

Aggregation

Financial instrument	ISIN code	Nature of transaction	Transaction date	Place of the transaction	Volume	Weighted average price
InDex Pharmaceuticals Holding AB BTA	SE0015503388	Subscription	05/02/2021	FIRST NORTH SWEDEN	200,000 (Quantity)	1.20 SEK
				Total:	200,000

<< Back